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VALIDITY OF THE DISABILITY OF THE ARM, SHOULDER AND HAND PATIENT-1 
REPORTED OUTCOME MEASURE (DASH) AND THE QUICKDASH WHEN USED 2 
IN DUPUYTREN’S DISEASE 3 
 4 
SUMMARY 5 
This study investigated aspects of the validity and reliability of the 30-item Disability 6 
of the Arm, Shoulder and Hand patient-reported outcome measure (DASH) and its 7 
relationship with the shorter 11-item QuickDASH in patients with Dupuytren’s 8 
disease. 9 
Seven hundred and fifty nine DASH questionnaires were studied, covering pre and 10 
postoperative patients undergoing different treatments for Dupuytren’s disease.  11 
Items related to pain rose early after treatment before returning to baseline, 12 
suggesting that studying pain is relevant during postoperative recovery.  Across all 13 
759 sets of responses, the QuickDASH agreed closely with the DASH.  In 14 
exploratory factor analysis, the DASH was not unidimensional, questioning the 15 
validity of the DASH summary score in Dupuytren’s disease. 16 
Further validation of existing PROMs for use in Dupuytren’s disease is needed.  17 
These data suggest that pain is a relevant symptom to study during postoperative 18 
recovery following treatment for Dupuytren’s disease. 19 
Level of Evidence: III 20 
21 
 2 
 22 
INTRODUCTION 23 
The use of patient-reported outcome measures (PROMs) in healthcare has been 24 
promoted in the UK (Darzi, 2008, Department of Health, 2010); international 25 
standards exist for their study (Mokkink et al., 2010).  Several PROMs have been 26 
used to evaluate Dupuytren’s disease; the 30-item Disability of the Arm, Shoulder 27 
and Hand tool (DASH) is the most popular (Ball et al., 2013).  However it has been 28 
suggested that the DASH may not be valid for use in Dupuytren’s disease 29 
(Beaudreuil et al., 2011, Packham, 2011), as it does not correlate closely with 30 
angular deformity (Engstrand et al., 2009, Jerosch-Herold et al., 2011, Zyluk and 31 
Jagielski, 2007); neither does the QuickDASH (Budd et al., 2011).  Furthermore, both 32 
include items that assess pain whereas it is claimed that Dupuytren’s disease may 33 
not be painful (Beaudreuil et al., 2011).  Other groups suggest that pain may be 34 
present (Hueston, 1963, Rodrigues et al., 2014, von Campe et al., 2012) and 35 
treatment-related pain may affect postoperative recovery. 36 
Much of the data describing the validity and reliability of the DASH was obtained from 37 
mixed cohorts involving upper limb conditions widely accepted as painful (Kennedy 38 
et al., 2011).  Other than the recent publication of the secondary analysis of a 39 
randomised controlled trial (Forget et al., 2014), there is limited data describing the 40 
DASH’s validity and reliability in Dupuytren’s disease specifically. 41 
Other PROMs that have been used to assess Dupuytren’s disease (Ball et al., 2013), 42 
include the Michigan Hand Questionnaire (MHQ) (Chung et al., 1998), the Patient 43 
Evaluation Measure (PEM) (Macey et al., 1995), the Unité Rhumatologique des 44 
Affections de la Main scale (URAM) (Beaudreuil et al., 2011), and the QuickDASH 45 
(Beaton et al., 2005) .  In a study of patients with a range of hand conditions, the 46 
DASH took longer to complete than the PEM, but was quicker than the MHQ (Dias et 47 
al., 2008).  Patients contributing to research, service evaluation or audit might be 48 
asked to complete more than one outcome measure.  For example, a specific PROM 49 
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and a generic measure to assess health-related quality of life, such as the EuroQol 5 50 
D (EQ5D) (Herdman et al., 2011), may be required to facilitate cost effectiveness 51 
analysis (NICE, 2008).  As a result, using PROMs that are quicker for the patient to 52 
complete may be more convenient and facilitate higher response rates. 53 
The QuickDASH comprises 11 of the 30 items in the DASH, and should be quicker to 54 
complete.  However, it has not been used extensively in Dupuytren’s disease (Ball et 55 
al., 2013). 56 
Consensus-based standards for the selection of health status measurement 57 
instruments (COSMIN) have been developed (Mokkink et al., 2010).  These define 58 
different aspects of the validity of PROMs. 59 
 Content validity assesses whether the items that comprise a PROM are an 60 
adequate reflection of what is trying to be measured.  It involves assessing 61 
the relevance and comprehensiveness of the items in a PROM. 62 
 Construct validity examines hypotheses about the PROM.  Such hypotheses 63 
may relate to its structural validity (internal relationships between items), 64 
hypothesis testing (assessing its relationship with other PROMs) and 65 
differences between groups (cross-cultural validity). 66 
 Internal consistency is the interrelatedness of the items within a PROM.  This 67 
assumes that all of the items that contribute to a summary score actually 68 
assess the same underlying entity, or factor (e.g. impairment of structures in 69 
the hand versus restriction of function involving the shoulder), i.e. they are 70 
‘unidimensional’. 71 
 Criterion validity tests a PROM against a ‘gold standard’.  The only accepted 72 
methodology for this is the comparison of a shortened PROM against the long 73 
version (e.g. the QuickDASH against the DASH). 74 
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 Responsiveness is the ability to detect change over time.  This differs from 75 
‘validity’, in that responsiveness assesses a change score, whereas validity 76 
assesses a single time point score. 77 
This cross sectional study assessed aspects of content validity, construct validity and 78 
reliability of the DASH in Dupuytren’s disease, and studied its relationship with the 79 
QuickDASH. 80 
81 
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 82 
METHODS 83 
Patient recruitment and data collection 84 
The data presented in this study were gathered as part of larger service evaluation.   85 
Patient recruitment took place between September 2011 and April 2013.  Exclusion 86 
criteria were cognitive impairment preventing informed consent and refusal of 87 
invitation to participate. 88 
The inclusion criteria were primary or recurrent Dupuytren’s disease and either 89 
patients awaiting fasciectomy or dermofasciectomy at one UK hand surgery centre or 90 
patients available for assessment at five UK hand surgery centres 1 year or 5 years 91 
(+/- 2 months) after their surgery when the primary author (JR) was available. 92 
Patients in the first inclusion criterion group, who were participating in an 93 
observational cohort study, were recruited at a routine preadmission clinic visit prior 94 
to surgery.  Those who were eligible and consented to participate completed the 95 
DASH in the clinic prior to surgery.  These patients were also sent questionnaires for 96 
completion by post at 3 weeks, 6 weeks and 1 year after surgery.  Patients who were 97 
scheduled for surgery to the left and right hand at different times during the study 98 
recruitment period were eligible for recruitment twice.  This happened on four 99 
occasions. 100 
Patients in the second inclusion criterion group, who were participating in a cross 101 
sectional study of postoperative outcome, were invited to participate with a letter 102 
explaining the project and inviting them to participate on a voluntary basis, with a 103 
fixed stipend offered to cover travel expenses.  A single surgeon (JR) assessed 104 
those who consented to participate in a special clinic.  The assessment included 105 
collection of demographic data and completion of the 30-item DASH questionnaire. 106 
Angular measurement: total passive extension deficit (TPED) 107 
Patients who completed PROMs in a clinic (as opposed to completion by post – 108 
which was the case for all 3 and 6 week postoperative measurements) had the 109 
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passive extension deficit of the treated digit assessed by a single examiner.  Total 110 
passive extension deficit (TPED) was calculated by adding the measured passive 111 
extension deficits of the metacarpophalangeal joint and proximal interphalangeal joint 112 
while the other joints of the digit were passively flexed.  The distal interphalangeal 113 
joint is rarely treated in our practice, and was not readily assessable with the model 114 
of goniometer used in the study.  The measurement thus minimised the influence of 115 
dynamism, but is likely to have underestimated the total active extension loss  116 
(Rodrigues et al., 2014). 117 
Content validity: relevance of pain questions 118 
The relevance of items assessing pain was assessed by extracting and analysing 119 
responses to question 24 of the DASH (which assesses pain, and is question 9 of the 120 
QuickDASH) and question 25 of the DASH (which assesses pain during specific 121 
activity; it is not in the QuickDASH) at different time points.  It was hypothesised that 122 
if pain items were relevant, they would change significantly through the recovery 123 
period. 124 
Construct validity and reliability 125 
The structural validity of the DASH was investigated by studying the internal 126 
relationships of the 30 different items in the DASH (how they related to each other) to 127 
assess whether the tool is “unidimensional”.  When used as instructed by the 128 
developer, the DASH generates a single summary ‘DASH score’, using all of the 30 129 
items.  This is in contrast to other tools such as the Michigan Hand Questionnaire, 130 
which generates several summary scores for different areas.  For the single DASH 131 
score to be valid, all items contributing to the score should measure, or ‘reflect’, the 132 
same underlying entity or ‘factor’, in this case upper limb function, i.e. the tool should 133 
be unidimensional (Mokkink et al., 2010).  To evaluate whether the DASH is 134 
unidimensional, exploratory factor analysis (EFA) was employed (Mokkink et al., 135 
2010).  EFA analyses the relationship between items when completed by different 136 
people to identify underlying latent factors that explain the variance in scores; the 137 
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differences seen between individuals across a population.  Some of the relevant 138 
concepts involved are defined in Table 1.  It was expected that the responses 139 
obtained would have a tendency towards low scores and so not fit a normal 140 
distribution.  This was examined by calculating the kurtosis and skewness for items.  141 
If the responses were not normally distributed, then logarithmic transformation of all 142 
items would be performed (Pallant, 2010) and their distributions then reassessed 143 
prior to factor analysis.  EFA may be performed using different statistical methods.  In 144 
this study, principal axis factoring was used to extract latent factors that were being 145 
reflected by the DASH’s items, and the number of factors extracted was determined 146 
and confirmed by using two different accepted techniques (scree plots and parallel 147 
analysis, see Table 1) (Cattell, 1966, Horn, 1965, Patil et al., 2007).  If the DASH is 148 
unidimensional, then there should only be one factor extracted.  Cronbach’s alpha 149 
was calculated to assess internal consistency.  However, this must be interpreted 150 
with caution if unidimensionality has not been confirmed. 151 
Relationship between the DASH and QuickDASH 152 
The DASH summary score was calculated using the standard formula provided: 153 
DASH=((a/b)-1) x 25 154 
Where “a” is the sum of the scores for the responses completed (each response 155 
could be scored between one and five), and “b” is the number of responses the 156 
patient completed. 157 
The QuickDASH summary score was calculated by extracting the answers to the 158 
relevant 11 questions.  The score was calculated using the same formula as for the 159 
DASH, only with these eleven items. 160 
Parametric analyses were used to compare the summary scores of the DASH and 161 
the QuickDASH as both have virtually continuous scales (each scored 0-100), and 162 
the sample comprised a large number of independent observations.  This is in 163 
keeping with the central limit theorem (Norman, 2010).  Pearson’s correlation 164 
coefficients were calculated between the total scores for the DASH and the 165 
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QuickDASH for a) the total sample and b) for different time point subgroups.  If the 166 
relationship between the QuickDASH and the DASH was not absolute and did not lie 167 
on the line of equality (i.e. the correlation coefficient was less than 1, the maximum 168 
possible correlation coefficient), then agreement was also studied.  Agreement was 169 
assessed by calculating 95% limits of agreement, using Bland-Altman analysis of the 170 
difference between the QuickDASH and the DASH (Bland and Altman, 1986).  The 171 
responsiveness was studied by calculating the effect size (mean change in score / 172 
standard deviation of baseline score). 173 
Handling of incomplete responses 174 
If more than three of the 30 responses are missing (i.e. fewer than 27/30 responses 175 
provided), then the DASH cannot be calculated (Kennedy et al., 2011).  If more than 176 
one response of the eleven is missing (i.e. fewer than 10/11 responses provided), 177 
then the QuickDASH cannot be calculated (Kennedy et al., 2011).  If either occurred, 178 
then that questionnaire was excluded from the study.  Consequently, some of the 179 
remaining questionnaires had some missing data (up to 3/30 responses missing for 180 
the DASH, or 1/11 missing for the QuickDASH).  As the study of the relationship 181 
between the DASH and QuickDASH used summary scores, this was of no 182 
consequence for that analysis.  In the EFA, all such questionnaires were included for 183 
analysis, but with missing responses excluded pairwise. 184 
Approvals 185 
This study was a minor element of a larger service evaluation project studying 186 
treatment outcome in Dupuytren’s disease.  In keeping with UK National Research 187 
Ethics Service guidance, it is exempt from ethical approval.  Approval as service 188 
evaluation was prospectively obtained from all centres involved.  Local information 189 
governance was prospectively obtained from all centres involved, including Caldicott 190 
Guardian approval where required. 191 
192 
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RESULTS 193 
Demographics 194 
768 DASH questionnaires were received.  These described the preoperative or 195 
postoperative assessment of 527 different procedures.  Nine cohort study 196 
questionnaires were incomplete to the extent that calculation of a summary score 197 
was not possible based on the guidance issued with the DASH or the QuickDASH, 198 
and they were excluded from all analysis.  Thus, 759 DASH questionnaires 199 
describing 527 procedures on 523 patients were analysed (this is represented 200 
graphically in the online appendix).  The 527 procedures comprised 126 needle 201 
aponeurotomies (fasciotomies), 327 fasciectomies and 74 dermofasciectomies.  The 202 
mean age at the time of assessment was 68 (range: 34 to 94) years; 403 of the 523 203 
(77%) patients were men.  The demographics of patients at time of completion of the 204 
759 questionnaires are shown in Table 2.  TPED measurements were made at the 205 
time of completion of the DASH scores in 522 of the 759 occasions (109 206 
preoperative and 413 postoperative). 207 
Content validity: relevance of pain questions 208 
Question 24 of the DASH (which is question 9 of the QuickDASH) requires 209 
participants to rate pain experienced in the arm, shoulder or hand in the preceding 210 
week on a scale from 1 (no pain) to 5 (severe pain).  This question was completed in 211 
750 of the 759 questionnaires studied.  The median score for question 24 was 2/5 212 
(“mild” pain) for the total study.  This was also the case when preoperative responses 213 
were studied alone.  Sixty-eight patients provided answers to question 24 at each of 214 
the preoperative, 3 weeks and 6 weeks time points.  When these responses were 215 
compared, there was a significant difference between them (p=0.003, repeated 216 
measures ANOVA test).  Specifically, scores were lower at 6 weeks than at 3 weeks 217 
(Tukey’s multiple comparison test).  Question 25 of the DASH (which is not part of 218 
the QuickDASH) rates pain when performing a specific activity.  It was completed in 219 
745 of 759 questionnaires.  The median score overall was again 2/5, and this was 220 
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also the case for preoperative responses.  The median score was 3/5 at 3-weeks 221 
postoperatively, falling back to 2/5 at 6 weeks postoperatively.  Sixty-one patients 222 
provided answers to question 25 at each of the preoperative, 3 weeks and 6 week 223 
time points.  Again, when these were compared, there was a significant difference 224 
between them (p=0.003, repeated measures ANOVA test).  Scores were higher at 3 225 
weeks than preoperatively and were lower at 6 weeks than at 3 weeks (Tukey’s 226 
multiple comparison test). 227 
Construct validity and reliability 228 
Across the subgroup that also had angular deformity measured, the DASH showed 229 
weak correlation with TPED (Pearson’s r = 0.30 (95% CIs: 0.22 to 0.38).  The 230 
QuickDASH also correlated weakly with TPED 0.29 (Pearson’s r = 95% CIs: 0.21 to 231 
0.37). 232 
After logarithmic transformation, 29 of the 30 DASH items had normal distributions.  233 
Most correlation coefficients between log transformed DASH items were over 0.3.  234 
Some correlation between the items is required for EFA, as it studies their inter-235 
relationships.  In the EFA, the presence of two major factors was suggested based 236 
on all common tests for determining factor numbers (see online appendix, confirmed 237 
by parallel analysis) (Cattell, 1966, Horn, 1965, Patil et al., 2007).  Hence the DASH 238 
was not truly ‘unidimensional’: its 30 items are likely to reflect two factors rather than 239 
one, which is what might be expected given that all DASH items are combined into a 240 
single score that is supposed to reflect ‘upper limb function’.  Thus, combining all 30 241 
to make a single DASH score may not be appropriate.  These two underlying factors 242 
that were identified in the EFA explained 57.5% and 5.3% of variance respectively.  243 
The results of the EFA are shown in Table 3, with the prerequisite tests in the 244 
footnotes (Kaiser, 1974).  The outputs from an EFA, called factor loadings, are the 245 
correlation coefficients between each item in the DASH questionnaire and the 246 
mathematical derived factor generated by the analysis.  Specific function items 247 
correlated well with Factor 1, whereas patient perception of impairment and 248 
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participation items (including pain-related items) generally correlated with Factor 2.  249 
The EFA was also rerun using raw, untransformed data, and generated the same 250 
pattern of results. 251 
Cronbach’s alpha for the DASH was 0.975.  However its interpretation was limited by 252 
finding that the DASH is potentially not unidimensional.  Cronbach’s alpha for the 253 
QuickDASH was 0.933.  Both results were consistent with there being redundancy of 254 
items within the scales. 255 
Relationship between the DASH and QuickDASH 256 
Across the entire study, the QuickDASH was higher than the DASH indicating 257 
apparently worse upper limb function (mean difference 1.6 (95%CIs: 1.3 – 1.8), 258 
paired t test.  However the QuickDASH correlated very well with the DASH, 259 
(Pearson’s r was 0.98 (95% CIs: 0.98 – 0.99), as shown in Chart 1). 260 
Linear regression analysis was performed with the Y-intercept constrained to y=0, as 261 
the QuickDASH must equal zero if the DASH equals zero.  Runs test confirmed that 262 
there was no significant deviation of the residuals from the model in the linear 263 
regression analysis (p=0.228).  The slope for the relationship between the two was: 264 
QuickDASH = 1.054 x DASH. 265 
Similar correlations were seen in separate preoperative, 3 week, 6 week, 1 year and 266 
5 year follow-up subgroup analyses (Table 4). 267 
The 95% limits of agreement between the QuickDASH and the DASH were -5.8 to 268 
+8.9 (Chart 2).  As relatively few differences were outside the 95% limits of 269 
agreement for mean scores under 30 (those with good upper limb function), further 270 
Bland-Altman analyses were performed for scores considered asymptomatic 271 
(<15/100), and scores considered symptomatic (>15/100) by the DASH’s creators 272 
(Kennedy et al., 2011).  When the mean of the DASH and QuickDASH for a patient 273 
was 15 or less (asymptomatic upper limb function), the 95% limits of agreement were 274 
-3.3 to +5.5, and when the mean was over 15 (symptomatic upper limb function), 275 
they were -7.8 to +12.3. 276 
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In terms of responsiveness from preoperative measurement to one year 277 
postoperative measurement, the effect size for the DASH was 0.58, and the effect 278 
size for the QuickDASH was 0.64. 279 
280 
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 281 
DISCUSSION 282 
Present study findings 283 
This study assessed several aspects of the validity and reliability of the DASH in 284 
Dupuytren’s disease, and its relationship with the QuickDASH. 285 
PROM items covering pain have been previously criticised in Dupuytren’s disease, 286 
but our patients did report preoperative upper limb pain.  This may have been due to 287 
other comorbid upper limb conditions rather than Dupuytren’s disease, nonetheless, 288 
this would affect the overall function of their upper limb.  Furthermore, pain levels 289 
rose early after surgery, and then fell back.  This is important to capture, as 290 
postoperative pain may differ between treatments, and affect early recovery.  Our 291 
data support the relevance of assessing pain when treating Dupuytren’s disease, 292 
such that scales that do not measure pain (such as the Unité Rhumatologique des 293 
Affections de la Main (URAM) (Beaudreuil et al., 2011)) may not provide a 294 
comprehensive assessment as a result. 295 
The DASH is not unidimensional, and its task-based items loading better with one 296 
construct, and patient perception items load best with another.  Some other PROMs 297 
are multidimensional and generate separate subscale scores.  Examples include the 298 
Michigan Hand Questionnaire, which has distinct subscales for entities that might be 299 
expected to behave as different ‘constructs’, such as function, pain and work (Chung 300 
et al., 1998).  However, the DASH is designed to generate a single summary score, 301 
and its items were not necessarily selected to measure specific distinct constructs.  302 
As a result, the different constructs identified here may not be easily interpreted.  The 303 
items loading with Factor 1 might do so as they are all task-based items.  The items 304 
that load with Factor 2 might do so as they are patient perception items.  However, 305 
an alternative explanation might be that items that load well with Factor 1 do so as 306 
they reflect activities involving the entire upper limb activities, and the items that load 307 
well with Factor 2 specifically reflect the patient’s experience of Dupuytren’s disease.  308 
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Either way, these data suggest that the DASH’s single summary score may not be 309 
appropriate in Dupuytren’s disease.  However, Factor 2 accounted for relatively little 310 
variance, such that its presence may not completely preclude the use of the DASH 311 
and its summary score in Dupuytren’s disease.  If used in future studies, its selection 312 
as an endpoint for future studies should be carefully considered. 313 
Interpreting whether agreement is adequate or not is a clinical decision (Bland and 314 
Altman, 1986).  Given that the minimum detectable change at the 95% confidence 315 
level (MDC95) for the DASH is around 13, and that the MDC95 of the QuickDASH is 316 
around 16 (Kennedy et al., 2011), then the 95% limits of agreement seen here are of 317 
similar magnitude to both tools’ abilities to detect true change, though these MDCs 318 
have not been specifically confirmed in Dupuytren’s disease.  Therefore, we believe 319 
that the level of agreement seen here would support the use of the QuickDASH as 320 
an alternative to the DASH if either were considered appropriate in Dupuytren’s 321 
disease.  Furthermore, their responsiveness was similar. 322 
Our large sample size allowed meaningful subgroup analysis, which demonstrated 323 
that close correlation between the two tools was seen at preoperative, early 324 
postoperative, and late outcome time points. 325 
Limitations 326 
There are limitations to this study.  Our sample included some patients who provided 327 
more than one measurement.  However, multiple measurements over time 328 
(preoperative, 3 weeks postop, 6 weeks post-operative and 1 year) do not constitute 329 
replicate measurements.  They are best considered as independent assessments, as 330 
the patient’s functional status is expected to be different at each time point, due to 331 
treatment of disease and progressive recovery. 332 
We used logarithmic transformation in an attempt to normalise the positive skew and 333 
kurtosis encountered.  Suggested methods for handling skewed data vary (Ferguson 334 
and Cox, 1993, Floyd and Widaman, 1995).  However, similar results were obtained 335 
when the EFAs were run using raw, untransformed data. 336 
 15 
Here, as in previous studies (Gummesson et al., 2006, Niekel et al., 2009), the 337 
QuickDASH and DASH were calculated from a single set of responses, on the DASH 338 
questionnaire’s proforma.  Intra-observer reproducibility, or test-retest reliability, is 339 
not observed when using a single set of responses.  However, we believe that our 340 
chosen methodology was the most appropriate to fulfil the specific objective of this 341 
study.  This was to determine whether the QuickDASH formula demonstrates 342 
acceptable criterion validity with the longer DASH formula for a given set of 343 
responses, in keeping with the COSMIN checklist (Mokkink et al., 2010).   344 
Test-retest reliability has been shown to be consistently high in previous studies, as 345 
summarised in the user manual for the DASH and the QuickDASH (Kennedy et al., 346 
2011).  The question of the present study is: “For a given set of responses, does the 347 
QuickDASH formula give you the same summary score as the DASH formula?”  If 348 
patients had completed the DASH and then the QuickDASH, then there would have 349 
been additional error due to intra-observer reproducibility.  This would have affected 350 
the ability to answer the study question. 351 
Relationship to existing literature 352 
Although the DASH is the most commonly used Patient Reported Outcome Measure 353 
(PROM) tool in Dupuytren’s research (Akhavani et al., 2015, Ball et al., 2013), 354 
Dupuytren’s-specific outcome measures are available, for example the URAM scale 355 
(Beaudreuil et al., 2011) and the Southampton Dupuytren’s score (Mohan et al., 356 
2014).  Preoperative Dupuytren’s disease is considered painless, and pain is not 357 
assessed in the URAM (Beaudreuil et al., 2011).  However, pain has been described 358 
as a symptom, particularly related to Dupuytren’s nodules (Hueston, 1963, Rodrigues 359 
et al., 2014, von Campe et al., 2012).  Our data demonstrated that pain was present 360 
preoperatively, increased at 3 weeks post-operative compared to baseline, returned 361 
to the preoperative level by 6 weeks postop, and did not disappear completely. 362 
The QuickDASH was produced from the DASH using item reduction methodology 363 
(Beaton et al., 2005).  The two showed good correlation in mixed cohorts of hand 364 
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surgery patients (Gummesson et al., 2006, Niekel et al., 2009).  However, correlation 365 
is not appropriate for studying agreement (Bland and Altman, 1986, Bland and 366 
Altman, 1990, Schuck, 2004).  We are not aware of any studies assessing 367 
agreement between the DASH and the QuickDASH in Dupuytren’s disease 368 
specifically, with the technique recommended by Bland and Altman (Bland and 369 
Altman, 1990).  Studying the strength of relationship between the two correlated 370 
measures, as has been done elsewhere, may conceal absolute differences in values 371 
between them.  Such differences are unmasked when agreement is studied using 372 
other techniques, as has been done here (Bland and Altman, 1986, Bland and 373 
Altman, 1990). 374 
Poor correlation between angular deformity and the DASH has been previously 375 
reported in Dupuytren’s disease (Degreef et al., 2009, Engstrand et al., 2009, 376 
Jerosch-Herold et al., 2011, Zyluk and Jagielski, 2007).  This has led to the 377 
suggestion that the DASH may not be valid for use in Dupuytren’s disease 378 
(Packham, 2011), although the basis for this claim was a series of only seven patient 379 
interviews (Pratt and Byrne, 2009).  Angular correction remains a very popular 380 
measure of outcome in the treatment of Dupuytren’s disease (Trickett et al., 2014, 381 
Verheyden, 2015).  However, such conclusions are dependent on angular deformity 382 
being a ‘gold standard’ for assessing Dupuytren’s disease, allowing the assessment 383 
of criterion validity of outcome measures including PROMs.  This is not appropriate: 384 
hand function is a latent construct that cannot be measured directly, and so no true 385 
‘gold standard’ for it can exist (Mokkink et al., 2010). 386 
Concerns about the absence of the expected unidimensionality for the DASH have 387 
been previously reported.  Forget and collagues investigated the structural validity of 388 
the DASH as the secondary analysis of a randomised controlled trial of splinting in 389 
Dupuytren’s disease (Forget et al., 2014).  EFA was performed on preoperative and 390 
early postoperative DASH scores from 153 fasciectomies and dermofasciectomies 391 
randomised to receiving postoperative splinting or no postoperative splinting.  It also 392 
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demonstrated a lack of unidimensionality for the DASH.  However the different 393 
groups of DASH items that loaded well on different factors could not be as easily 394 
explained as they can in the present study.  The present study evaluated 395 
preoperative, early postoperative and late postoperative outcomes of over 500 396 
procedures, including needle aponeurotomies, and in contrast, our EFA showed a 397 
clear division between task items and patient perception items.  Another study that 398 
investigated a heterogeneous cohort comprising a range of upper limb conditions 399 
(mainly affecting the shoulder) and only a small minority with Dupuytren’s disease 400 
found the DASH items loaded on three distinct factors in EFA, and this was 401 
confirmed using other techniques classified as confirmatory factor analysis 402 
(Franchignoni et al., 2010).  As with the present study, patient perception items 22 to 403 
30 loaded separately from the main factor, but they also found that of the other items, 404 
those relating to manual function loaded distinctly from those assessing shoulder 405 
functions.  Given that the equivalent of the present study’s Factor 1 was two separate 406 
factors in a mixed cohort including shoulder patients suggests that Factor 1 is not a 407 
clean and reliable indicator of hand function in Dupuytren’s disease.  Our data further 408 
question the structural validity of the DASH in Dupuytren’s disease, and by 409 
association, the QuickDASH.  Due to this, we believe that it is neither necessary nor 410 
appropriate to subject the DASH to further analyses such as Rasch analysis (Tesio, 411 
2003).  Instead, other PROMs that also assess pain, such as the MHQ or the PEM, 412 
may be more appropriate for the study of Dupuytren’s disease. 413 
Summary 414 
This study supports the assessment of pain when studying recovery from 415 
Dupuytren’s surgery.  The QuickDASH show acceptable agreement with the full 416 
DASH.  However, the DASH may not be structurally valid for use in Dupuytren’s 417 
disease, and further study of existing PROMs for use in Dupuytren’s disease is 418 
needed. 419 
420 
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Appendix 1: Flow diagram demonstrating time points from which complete 
questionnaires were received 
 
Cohort study 
Preoperative assessment 
(Questionnaires & angles) 
(n=114) 
3-week postal questionnaire 
(n=83) 
6-week postal questionnaire 
(n=85) 
1-year postal questionnaire 
(n=64) 
Cross sectional study 
OR 
1-year postoperative 
assessment (Questionnaires 
& angles) (n=252) 
5-year postoperative 
assessment (Questionnaires 
& angles) (n=161) 
Appendix 2: Scree plot of exploratory factor analysis for log transformation of DASH 
items 
 
 
The curve flattens from factor 3 onwards.  Based on Cattell’s test, this supports the 
extraction of factors 1 and 2.  This was confirmed using parallel analysis, and only 
these two factors had Eigenvalues over one. 
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Chart 1: Scatterplot of QuickDASH versus DASH (n=759). 2 
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Chart 2: Bland-Altman plot of total sample, with 95% limits of agreement shown as 
dotted lines 
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Table 1: Data handling and relevant statistical concepts 
Aspect Studied Method(s) Used Concept(s) Description 
Content validity Cohort study of pain 
items 
Comprehensiveness 
& Relevance 
Content validity considers whether PROM items are relevant to what is being measured, and 
whether the scale overall is comprehensive. 
Distribution of item 
responses 
Kurtosis & skewness Kurtosis Defines the sharpness of the peak of a distribution of data 
  Skewness Defines the amount of asymmetry of a distribution of data 
Construct validity 
(structural validity) 
Exploratory Factor 
Analysis 
Unidimensionality All items contributing to a summary score reflect the same underlying factor (some PROMs 
generate more than one summary score, each describing a different subscale of the PROM) 
  Factor Factor analysis aims to describe the variation in measured items that correlate with each other in 
terms of fewer unobserved ‘factors’ 
  Principal axis factoring A form of factor analysis in which factors are extracted based on common variance, rather than 
total variance. 
  Eigenvalue Describes the amount of the total variance that is explained by a particular factor 
  Catell’s scree plot Determines the number of factors to extract.  All potential factors are plotted in order of 
Eigenvalues (see Chart 1).  The turning point where the connecting line flattens sharply is the point 
at which the last significant factor has been passed, as further factors represent a flat level of 
background noise (Catell, 1966). 
  Parallel analysis Determines the number of factors to extract.  A second set of Eigenvalues is generated, but which 
are based entirely on chance.  All factors in the real model with Eigenvalues greater than their 
counterparts in the chance model are significant and are then extracted.  Avoids the risk of bias 
that exists with scree plot interpretation (Horn, 1965). 
  Kaiser-Meyer-Olkin 
statistic 
Assesses sampling adequacy.  It lies between 0-1, describing the proportion of variance that is 
common variance.  The minimum acceptable level for analysis being 0.6, and >0.9 being 
described as ‘marvellous’ (Kaiser, 1974). 
  Bartlett’s test of 
sphericity 
Assesses whether an identity matrix would result if correlations between the items included were 
studied, i.e. whether the correlation between all of the DASH items is zero.  Some correlation 
between items is needed for EFA.  A significant result is achieved if the data is suitable for EFA. 
  Factor loading The output of EFA.  Described how closely an item correlates with a factor. 
  Rotation Presents the factor loadings in a manner that makes interpretation more straightforward, resulting 
in a pattern matrix.  Only possible when more than one factor is extracted.  When done, the 
majority of the items may each show strong loading with one of the factors, a situation described 
as simple structure. 
Reliability Cronbach’s alpha Internal consistency Studies the inter-relatedness between items within a scale.  However, it is dependent on the scale 
being unidimensional and reflective 
Relationship between 
DASH and 
QuickDASH 
Bland-Altman plots Agreement Studies the relationship between two variables that are expected to correlate.  In such 
circumstances, reporting correlation is common, but may not be appropriate. 
 
Table 2: Subgroups and demographics of completed questionnaires 1 
Subgroup Number of complete 
questionnaires (incompletes) 
Procedure type Mean age at 
assessment (range) 
Proportion male 
Total 759 (9) 130 aponeurotomies 
494 fasciectomies 
135 dermofasciectomies 
 
68 (34-94) 592/759 (78%) 
Preoperative 114 (3) N/A 
 
67 (34-90) 88/114 (77%) 
3 weeks postop 83 (0) 2 aponeurotomies 
57 fasciectomies 
24 dermofasciectomies 
 
67 (34-90) 66/83 (80%) 
6 weeks postop 85 (3) 2 aponeurotomies 
62 fasciectomies 
21 dermofasciectomies 
68 (34-90) 68/85 (80%) 
 1 year postop 316 (3) 105 aponeurotomies 
168 fasciectomies 
43 dermofasciectomies 
 
68 (35-91) 249/316 (79%) 
5 years postop 161 (0) 19 aponeurotomies 
126 fasciectomies 
16 dermofasciectomies 
71 (39-89) 121/161 (75%) 
 2 
 3 
Table 3: Exploratory factor analysis output of log-transformed DASH items (Pattern 1 
matrix with two-factor solution and oblimin rotation) 2 
[The pattern coefficients may be considered similar to correlation coefficients 3 
between the item and the factors was derived in EFA.  They may range from -1 4 
(perfect inverse correlation), through 0 (no correlation), to +1 (perfect correlation)] 5 
Item 
number 
Item question Pattern coefficient 
with factor 1 
Pattern coefficient 
with factor 2 
12 Difficulty changing a light bulb overhead 0.86 -0.05 
14 Difficulty washing your back 0.84 -0.09 
7 Difficulty doing heavy household chores 0.84 0.05 
5 Difficulty pushing open a heavy door 0.82 -0.06 
13 Difficulty washing or blow drying hair 0.82 -0.03 
9 Difficulty making a bed 0.80 0.03 
16 Difficulty using a knife to cut food 0.80 0.01 
11 Difficulty carrying a heavy object (>10 lbs) 0.80 0.04 
8 Difficulty gardening 0.80 0.08 
6 Difficulty placing an object on a shelf above 
head 
0.78 -0.04 
17 Difficulty with recreational activities that require 
little effort 
0.78 -0.05 
4 Difficulty preparing a meal 0.77 0.07 
18 Difficulty with recreational activities in which 
force is taken through the limb 
0.73 0.13 
21 Difficulty with sexual activities 0.72 -0.11 
19 Difficulty with recreational activities in which 
the arm moves freely 
0.71 0.12 
3 Difficulty turning a key 0.69 0.03 
15 Difficulty putting on a pullover sweater 0.68 0.09 
20 Difficulty managing transportation needs 0.68 0.02 
10 Difficulty carrying a shopping bag/briefcase 0.67 0.15 
2 Difficulty writing 0.63 0.02 
1 Difficulty opening a tight or new jar 0.61 0.15 
22 To what extent has your problem interfered 
with normal social activities? 
0.45 0.37 
23 To what extent has your problem interfered 
with work or other daily activities? 
0.44 0.42 
24 Rate your arm, shoulder or hand pain -0.06 0.90 
25 Rate your arm, shoulder or hand pain when 
performing a specific activity 
-0.02 0.87 
28 Rate the stiffness in your arm, shoulder or 
hand 
0.08 0.72 
27 Rate the weakness in your arm, shoulder or 
hand 
0.17 0.69 
29 How much difficulty have you had sleeping 
because of pain in the limb? 
0.10 0.62 
26 Rate the tingling in the arm, shoulder or hand -0.04 0.59 
30 Is this true: I feel less capable, confident or 
useful because of the limb problem? 
0.29 0.51 
 6 
N.B.  Items have been sorted by size of factor loading.  Large factor loadings (>0.3) 7 
are shown in bold. 8 
The Kaiser-Meyer-Olkin statistic for the analysis was 0.97 and Bartlett’s test of 9 
sphericity was highly statistically significant (Kaiser, 1974). 10 
Table 4: Mean DASH and QuickDASH scores and their correlations, by time point 1 
TIME POINT MEAN DASH 
(95% CIs) 
MEAN 
QuickDASH 
(95% CIs) 
PEARSON’s r 
(95% CIs) 
Preoperative 27 
(23-31) 
28 
(24-32) 
0.98 (0.97-0.99) 
3 week postoperative 37 
(33-42) 
41 
(36-46) 
0.97 (0.95-0.98) 
6 week postoperative 22 
(18-26) 
24 
(20-28) 
0.98 (0.97-0.99) 
1 year postoperative 11 
(9-13) 
12 
(10-14) 
0.99 (0.98-0.99) 
5 years postoperative 11 
(9-13) 
12 
(10-15) 
0.97 (0.96-0.98) 
 2 
 3 
